However, CXCL1, one of the major neutrophil-recruiting chemokines in COPD, was surprisingly increased by budesonide treatment (Figure 7D), suggesting that steroid treatment may paradoxically further perpetuate IL-36γ inflammation by increasing neutrophil recruitment. Here, CXCL1 is linked to chronic obstructive pulmonary disease.